Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
US7504104 | NA | Human CDR-grafted antibody and antibody fragment thereof |
Jan, 2028
(4 years from now) |
Ingredients: MOGAMULIZUMAB-KPKC
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic